|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0030705,
umls-concept:C0355642,
umls-concept:C0445202,
umls-concept:C0452253,
umls-concept:C0475311,
umls-concept:C0494165,
umls-concept:C0555952,
umls-concept:C0677582,
umls-concept:C0728940,
umls-concept:C1134564,
umls-concept:C1273870,
umls-concept:C1514818,
umls-concept:C1880198,
umls-concept:C1880253
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2003-8-20
|
|
pubmed:abstractText |
Although hepatic arterial infusion (HAI) is widely performed as a prophylactic chemotherapy for patients who have undergone a curative resection of a metastatic liver tumor from colorectal cancer, the optimal management of implantable ports and catheters after the cessation of such adjuvant therapy remains to be elucidated.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0941-1291
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
679-83
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12928845-Anticoagulants,
pubmed-meshheading:12928845-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12928845-Catheterization,
pubmed-meshheading:12928845-Chemotherapy, Adjuvant,
pubmed-meshheading:12928845-Colorectal Neoplasms,
pubmed-meshheading:12928845-Disease-Free Survival,
pubmed-meshheading:12928845-Female,
pubmed-meshheading:12928845-Heparin,
pubmed-meshheading:12928845-Hepatectomy,
pubmed-meshheading:12928845-Hepatic Artery,
pubmed-meshheading:12928845-Humans,
pubmed-meshheading:12928845-Infusion Pumps, Implantable,
pubmed-meshheading:12928845-Infusions, Intra-Arterial,
pubmed-meshheading:12928845-Liver Neoplasms,
pubmed-meshheading:12928845-Male,
pubmed-meshheading:12928845-Middle Aged,
pubmed-meshheading:12928845-Neoplasm Recurrence, Local
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Management of hepatic arterial infusion port following prophylactic regional chemotherapy in patients who have undergone curative resection of colorectal liver metastases.
|
|
pubmed:affiliation |
Department of Surgery, NTT West Osaka Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka 543-8922, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
